Cattle Health Market Size (2024 - 2029)

The cattle healthcare market is projected to experience growth over the forecast period, driven by increased research and development expenditures, a rising burden of cattle diseases, and proactive initiatives by governments and animal welfare organizations. The market's expansion is further supported by the growing demand for animal products and the production increases in key regions such as India and the United States. Additionally, the introduction of innovative healthcare products is expected to enhance treatment options for cattle, contributing to market growth. However, challenges such as inadequate infrastructure, limited funding, and high costs associated with animal testing and veterinary services may impede the market's progress.

Market Size of Cattle Health Industry

Cattle Health Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 8.43 Billion
Market Size (2029) USD 11.11 Billion
CAGR (2024 - 2029) 5.67 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Cattle Health Market Major Players

*Disclaimer: Major Players sorted in no particular order

Cattle Health Market Analysis

The Cattle Health Market size is estimated at USD 8.43 billion in 2024, and is expected to reach USD 11.11 billion by 2029, growing at a CAGR of 5.67% during the forecast period (2024-2029).

  • The emergence of the COVID-19 pandemic has had an impact on the cattle health market as it affected the pharmaceutical supply chain, and several diagnostic and treatment procedures were affected due to the lockdown restrictions imposed by various countries around the world. Hence the demand for cattle healthcare products was reduced. For example, as per the 2021 report by Zoetis Inc., due to COVID-19, the need for their products was reduced, which negatively affected their business. Hence, COVID-19 negatively affected the market during the pandemic. However, with the reduction in COVID-19 cases, the reopening of global economies, and the resumption of trade in veterinary products and services, the cattle health market is expected to recover from the impact of COVID-19 in the next two-three years.
  • The market for cattle health is being driven by factors such as increasing R&D expenditure in the cattle health sector, the rising burden of cattle disease, and increasing initiatives by government and animal welfare associations. For instance, the IntechOpen Journal article published in November 2021 reported that mastitis is an inflammation of the mammary gland in which pain persists in both or one mammary gland and is a prevalent disease in the bovines. It also reported that in India, in buffaloes from rural and urban dairy farmers, there was nearly an 18.74% prevalence of clinical mastiti in buffaloes from rural and urban dairy farmers. Thus, such a high incidence of such diseases is expected to increase the consumption of drugs and the usage of medical devices for cattle health and thus, increasing the cattle health market growth over the forecast period.
  • Furthermore, the increasing value and volume of animal product and rising demand is expected to increase the production of animal products. For instance, India and the United States are becoming significant hubs for livestock and poultry production, which is also acting as a major factor for market growth. For instance, according to an article published by Koala Guide LLC in June 2021, India, the United States, Pakistan, China, and Brazil are the five largest producers of milk. India, the United States, and Pakistan account for about 40% of the total milk production in the world. Thus, increasing productivity is expected to increase market growth in the future. Furthermore, product launches are another factor in market growth as new and innovative products provide better treatment for cattle which increases their adoption and thus increases market growth. For instance, in August 2022, two institutes of the Indian Council of Agricultural Research (ICAR) developed a vaccine for lumpy skin disease, which is spreading in India. Thus, the abovementioned factors are expected to fuel growth in the cattle health market over the forecast period. However, the lack of infrastructure and funding, coupled with the increasing costs of animal testing and veterinary service, are expected to hinder the market growth.

Cattle Health Industry Segmentation

As per the scope of the report, cattle healthcare includes the products that are used for the treatment and diagnosis of cattle against various medical conditions and diseases.

 The Cattle Health Market is segmented by product type (by therapeutics (vaccine, parasiticide, anti-infective, medical feed additive, and other therapeutics) and by diagnostics (immunodiagnostic test, molecular diagnostics, diagnostic imaging, clinical chemistry, and other diagnostics), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.

By Product Type
By Therapeutics
Vaccine
Parasiticide
Anti-infective
Medical Feed Additive
Other Therapeutics
By Diagnostics
Immunodiagnostic Test
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Cattle Health Market Size Summary

The cattle healthcare market is poised for significant growth over the forecast period, driven by increasing research and development investments, a rising burden of cattle diseases, and proactive initiatives by government and animal welfare organizations. The market experienced a temporary setback due to the COVID-19 pandemic, which disrupted pharmaceutical supply chains and reduced demand for healthcare products. However, as global economies reopen and trade in veterinary products resumes, the market is expected to recover. The prevalence of diseases such as mastitis in bovines is anticipated to boost the consumption of drugs and medical devices, further propelling market expansion. Additionally, the growing demand for animal products, particularly in countries like India and the United States, is expected to enhance livestock production, contributing to market growth.

Technological advancements and product innovations are also key factors driving the cattle healthcare market. The introduction of new diagnostic imaging technologies and veterinary products, such as the VXR Veterinary X-Ray Room and the open-bore CT scanner by Xoran Technologies, are expected to improve diagnostic capabilities and treatment options for cattle. The import and export of cattle, particularly between Mexico and the United States, necessitate robust diagnostic and vaccination protocols, further supporting market growth. The market is moderately competitive, with major players like Zoetis Inc., Boehringer Ingelheim, and Elanco Animal Health leading the industry. Strategic collaborations and product launches, such as the development of a vaccine for lumpy skin disease in India, are expected to drive further growth in the cattle healthcare sector.

Explore More

Cattle Health Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing R&D Expenditure in the Cattle Health Sector

      2. 1.2.2 Rising Burden of Cattle Diseases

      3. 1.2.3 Increasing Initiatives by Government and Animal Welfare Associations

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Infrastructure and Funding

      2. 1.3.2 Increasing Costs of Animal Testing and Veterinary Services

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 By Therapeutics

        1. 2.1.1.1 Vaccine

        2. 2.1.1.2 Parasiticide

        3. 2.1.1.3 Anti-infective

        4. 2.1.1.4 Medical Feed Additive

        5. 2.1.1.5 Other Therapeutics

      2. 2.1.2 By Diagnostics

        1. 2.1.2.1 Immunodiagnostic Test

        2. 2.1.2.2 Molecular Diagnostics

        3. 2.1.2.3 Diagnostic Imaging

        4. 2.1.2.4 Clinical Chemistry

        5. 2.1.2.5 Other Diagnostics

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Italy

        5. 2.2.2.5 Spain

        6. 2.2.2.6 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 India

        4. 2.2.3.4 Australia

        5. 2.2.3.5 South Korea

        6. 2.2.3.6 Rest of Asia-Pacific

      4. 2.2.4 Middle East and Africa

        1. 2.2.4.1 GCC

        2. 2.2.4.2 South Africa

        3. 2.2.4.3 Rest of Middle East and Africa

      5. 2.2.5 South America

        1. 2.2.5.1 Brazil

        2. 2.2.5.2 Argentina

        3. 2.2.5.3 Rest of South America

Cattle Health Market Size FAQs

The Cattle Health Market size is expected to reach USD 8.43 billion in 2024 and grow at a CAGR of 5.67% to reach USD 11.11 billion by 2029.

In 2024, the Cattle Health Market size is expected to reach USD 8.43 billion.

Cattle Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)